Subscriber Authentication Point
lvrea
Home All issues Réanimation, 24 5 (2015) 527-541 Article references

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from Lavoisier database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020

Mitchell L. Waters, Paul I. Dargan, Christopher Yates, Alison M. Dines, Florian Eyer, Isabelle Giraudon, Fridtjof Heyerdahl, Knut Erik Hovda, Matthias E. Liechti, Òscar Miró, Odd Martin Vallersnes, Kurt Anseeuw, Robertas Badaras, Marcin Bitel, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Birgit Gartner, Ketevan Gorozia, Damjan Grenc, et al.
Clinical Toxicology 62 (6) 378 (2024)
https://doi.org/10.1080/15563650.2024.2346125

The novel psychoactive substances epidemic: A scientometric perspective

Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola and Gianluca Esposito
Addiction Neuroscience 5 100060 (2023)
https://doi.org/10.1016/j.addicn.2022.100060

Simultaneous determination of 4F-MDMB BINACA, a new synthetic cannabinoid, and its metabolites in human blood samples by LC-MS/MS

Oya YETER
Journal of the Turkish Chemical Society Section A: Chemistry 7 (3) 827 (2020)
https://doi.org/10.18596/jotcsa.770427

Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set

Caitlin E. Wolfe, David M. Wood, Alison Dines, et al.
NeuroToxicology 73 183 (2019)
https://doi.org/10.1016/j.neuro.2019.04.003

Cannabinoid Type 1 Receptor (CB1) Ligands with Therapeutic Potential for Withdrawal Syndrome in Chemical Dependents of Cannabis sativa

Jaderson V. Ferreira, Gisele A. Chaves, Bianca L. B. Marino, Kessia P. A. Sousa, Lucilene R. Souza, Maiara F. B. Brito, Hueldem R. C. Teixeira, Carlos H. T. P. da Silva, Cleydson B. R. Santos and Lorane I. S. Hage‐Melim
ChemMedChem 12 (16) 1408 (2017)
https://doi.org/10.1002/cmdc.201700129

Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015

Rachelle Abouchedid, Simon Hudson, Natalie Thurtle, et al.
Clinical Toxicology 55 (5) 338 (2017)
https://doi.org/10.1080/15563650.2017.1287373

Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

Samuel D. Banister, Mitchell Longworth, Richard Kevin, et al.
ACS Chemical Neuroscience 7 (9) 1241 (2016)
https://doi.org/10.1021/acschemneuro.6b00137

Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation

Rachelle Abouchedid, James H. Ho, Simon Hudson, et al.
Journal of Medical Toxicology 12 (4) 396 (2016)
https://doi.org/10.1007/s13181-016-0571-7